Design for a multicenter, randomized, sham-controlled study to evaluate safety and efficacy after treatment with the Nuvaira® lung denervation system in subjects with chronic obstructive pulmonary disease (AIRFLOW-3)

BACKGROUND: Targeted lung denervation (TLD) is a bronchoscopically delivered ablation therapy that selectively interrupts pulmonary parasympathetic nerve signaling. The procedure has the potential to alter airway smooth muscle tone and reactivity, decrease mucous secretion, and reduce airway inflamm...

Descripción completa

Detalles Bibliográficos
Autores principales: Slebos, Dirk-Jan, Degano, Bruno, Valipour, Arschang, Shah, Pallav L., Deslée, Gaetan, Sciurba, Frank C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020591/
https://www.ncbi.nlm.nih.gov/pubmed/32054473
http://dx.doi.org/10.1186/s12890-020-1058-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020591/
https://www.ncbi.nlm.nih.gov/pubmed/32054473
http://dx.doi.org/10.1186/s12890-020-1058-5

Ejemplares similares